Bernardotto S, Frasson I, Faravelli S, Morelli A, Schiavon E, Moscatiello G, et al. Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly. Biomaterials. 2023;303:122394 pubmed publisher

Seixas M, Bartolomeo C, Lemes R, Nicoliche T, Okuda L, Martins L, et al. Disruptive 3D in vitro models for respiratory disease investigation: A state-of-the-art approach focused on SARS-CoV-2 infection. Biomater Biosyst. 2023;11:100082 pubmed publisher

Wu C, Yang Y, Lin Y, Shu L, Cheng Y, Liu H, et al. The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Heliyon. 2023;9:e17701 pubmed publisher

Colom M, Vucinic J, Adolf Bryfogle J, Bowman J, Verel S, Moczygemba I, et al. Deep Evolutionary Forecasting identifies highly-mutated SARS-CoV-2 variants via functional sequence-landscape enumeration. Res Sq. 2022;: pubmed publisher

Kim T, Kim J, Kwon H, Jeon S, Lee S, Jung H, et al. Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation. Antiviral Res. 2022;208:105428 pubmed publisher

Park J, Park M, Kim Y, Jun Y, Lee U, Oh C. Apelin as a new therapeutic target for COVID-19 treatment. QJM. 2022;: pubmed publisher

Parker E, Anderson C, Zeller M, Tibi A, Havens J, Laroche G, et al. Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions. Nat Commun. 2022;13:4784 pubmed publisher

Mekhail K, Lee M, Sugiyama M, Astori A, St Germain J, Latreille E, et al. FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses. J Lipid Res. 2022;63:100256 pubmed publisher

Nagappan A, Kim K, Moon Y. Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma. Cell Biol Toxicol. 2022;: pubmed publisher

Muena N, García Salum T, Pardo Roa C, Avendaño M, Serrano E, Levican J, et al. Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals. EBioMedicine. 2022;78:103972 pubmed publisher

Pinto A, Rai R, Brown J, Griffin P, Edgar J, Shah A, et al. Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium. Nat Commun. 2022;13:1609 pubmed publisher

Tsai M, Shih W, Yang Y, Lin Y, Chang G, Hsu C, et al. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Biomed Pharmacother. 2022;149:112802 pubmed publisher

Ferrucci V, De Antonellis P, Quarantelli F, Asadzadeh F, Bibbò F, Siciliano R, et al. Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation. Int J Mol Sci. 2022;23: pubmed publisher

Zhang L, Dutta S, Xiong S, Chan M, Chan K, Fan T, et al. Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants. Nat Chem Biol. 2022;18:342-351 pubmed publisher

Grishin A, Dolgova N, Landreth S, Fisette O, Pickering I, George G, et al. Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen. J Mol Biol. 2022;434:167357 pubmed publisher

Christodoulou I, Rahnama R, Ravich J, Seo J, Zolov S, Marple A, et al. Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection. Front Immunol. 2021;12:763460 pubmed publisher

Zhang L, Dutta S, Xiong S, Chan M, Chan K, Fan T, et al. Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants. bioRxiv. 2021;: pubmed publisher

Sansico F, Miroballo M, Bianco D, Tamiro F, Colucci M, Santis E, et al. COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling. Biomedicines. 2021;9: pubmed publisher

Durdagi S, Avsar T, Orhan M, Serhatlı M, Balcioglu B, Ozturk H, et al. The neutralization effect of montelukaston SARS-CoV-2 is shown by multiscale in silicosimulations and combined in vitro studies. Mol Ther. 2021;: pubmed publisher

Dogan K, Erol E, Didem Orhan M, Degirmenci Z, Kan T, Gungor A, et al. Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2. Phytochem Anal. 2021;: pubmed publisher

Havranek B, Chan K, Wu A, Procko E, Islam S. Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity. J Chem Inf Model. 2021;61:4656-4669 pubmed publisher

Tsai M, Yang Y, Lin Y, Chang G, Hsu C, Yeh R, et al. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. Biomed Pharmacother. 2021;142:112011 pubmed publisher

Cecon E, Burridge M, Cao L, Carter L, Ravichandran R, Dam J, et al. SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET. Cell Chem Biol. 2021;: pubmed publisher

Zhang Q, Gefter J, Sneddon W, Mamonova T, Friedman P. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion. iScience. 2021;24:102770 pubmed publisher

Kim T, Jeon S, Jang Y, Gotina L, Won J, Ju Y, et al. Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Exp Mol Med. 2021;53:956-972 pubmed publisher

Laffeber C, de Koning K, Kanaar R, Lebbink J. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants. J Mol Biol. 2021;433:167058 pubmed publisher

Suh J, Kim H, Kim T. Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor. Sens Actuators B Chem. 2021;334:129663 pubmed publisher

Chan K, Dorosky D, Sharma P, Abbasi S, Dye J, Kranz D, et al. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 2020;369:1261-1265 pubmed publisher

Procko E. The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. bioRxiv. 2020;: pubmed publisher